VolitionRx Limited announced that it will receive $100,000 in funding on March 12, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9198 USD | +7.10% | +8.21% | +28.28% |
Apr. 26 | VolitionRx Limited Announces Board Changes | CI |
Apr. 23 | VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.28% | 70.52M | |
-19.82% | 10.81B | |
+50.92% | 3.36B | |
-32.83% | 2.22B | |
-14.31% | 2.16B | |
-27.44% | 1.55B | |
+21.68% | 1.04B | |
-3.28% | 746M | |
-32.75% | 425M | |
-43.57% | 405M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- VolitionRx Limited announced that it expects to receive $0.1 million in funding